1'752 companies found
HAB Invest AG
Lucerne · Since 2009
The core activity of HAB Invest AG is the development, manufacture and distribution of medical products and pharmaceuticals.
Haleon CH SARL
Prangins · Since 1991
Hans Rentsch AG
Speicher · Since 1978
The core activity of Hans Rentsch AG is the distribution of naturopathic medicinal products, including phytotherapeutic agents, homeopathic remedies and dietary supplements, for complementary medicine.
Hartis-Pharma SA
Nyon · Since 2016
The core activity of HARTIS Pharma consists of researching and developing therapeutics based on the potential benefits of High-Density-Lipoprotein (HDL), particularly through the regulation of membrane cholesterol and its liposoluble cargo activity of antioxidants. The company focuses on developing treatments for medical needs that have not been adequately addressed or cannot be treated sufficiently.
Haut-Lac Ecole Internationale Bilingue SA
St-Légier-La Chiésaz · Since 2003
Thermo Fisher Scientific is a leading company in the life science industry, specializing in the development, manufacture and distribution of products and services for research, development and production of pharmaceuticals, biotechnology and environmental analysis. The company's core activities include research and development, manufacturing of laboratory equipment and supplies, diagnostics, pharmaceutical development and production, as well as environmental analysis.
Haya Therapeutics SA
Epalinges · Since 2019
The company develops precise therapeutics based on genome research and biotechnology. It focuses on the development of medicines and therapies, particularly in the field of cardiovascular diseases and regenerative medicine. The core activity includes research and development of new medicines, identification and evaluation of new business opportunities, conducting due diligence reviews, and managing portfolio companies.
Healiva SA
Lugano · Since 2020
Healiva SA is a patient‑centric biotech company developing personalized therapies for chronic wound care. It combines cell therapies, enzyme technology and medical devices and is developing products such as EpiDex (epidermal cell graft), AQUAtryp (enzymatic debriding agent), Healiva 002 (allogeneic cell spray) and Healiva 004 (autologous blood patch) for hard‑to‑heal wounds.
HealthWatch Swiss AG
Baar · Since 2007
The core activity of HealthWatch Swiss is the development, licensing and marketing of pharmaceuticals, particularly through strategic partnerships and licenses, to provide patients with access to high-quality medications while simultaneously opening up new business areas to ensure sustainable growth.
HEKETISS SA
Plan-Les-Ouates · Since 2021
The core activity of HekeTiss is the development and marketing of innovative therapies for the treatment of chronic wounds, particularly through the use of stem cells derived from adipose tissue. The company focuses on the development of skin substitute products, such as TrophiPatch, a cell-based skin patch that promotes wound healing through the angiogenic and regenerative properties of stem cells.
Helvepharm AG
Frauenfeld · Since 2001
The core activity of Zentiva is the development, production and marketing of generics, i.e. cost-effective copycat medicines, in various therapeutic areas, including oncology.
Helvetica-Pharm GmbH
Arbon · Since 2018
The core activity of Helvetica Pharm is the development, manufacture and marketing of sustainable biological products, in particular those based on natural ingredients that can be used for the prevention or treatment of diseases.
Helvetic Pharma AG
Schenkon · Since 2020
The core activity of Helvetic Pharma AG is the development, manufacture and distribution of dietary supplements, vitamins and minerals with the highest bioavailability. The company uses a patented micellization process to produce products with nearly 100% bioavailability. The distribution of the products takes place exclusively on the Swiss market and in Liechtenstein.
Helvion Pharma AG
Zug · Since 2024
Hempcare GmbH
Wangen Sz · Since 2018
The core activity of Swiss HempCare is the production and distribution of products made from the medicinal plant Cannabis Sativa L., particularly CBD products. The company focuses on the development and production of high-quality core products tailored to the needs of its customers.
Herbamed AG
St. Gallen · Since 1983
Herbamed AG manufactures herbal mother tinctures, homeopathic remedies and pharmaceuticals, offering around 600 tinctures in its standard range produced according to the general requirements of the Homoeopathic Pharmacopoeia. The company also produces dilutions, triturations and globules (including veterinary medicines) and provides contract manufacturing and documentation services.
Herbonis AG
Augst Bl · Since 2004
Herb-pharma AG
Zurich · Since 2008
The core activity of Herb-Pharma is the development, manufacture and marketing of cosmetic products, dietary supplements and pharmaceuticals based on natural ingredients and biotechnological products. The company focuses particularly on skin care and develops innovative products based on scientific findings and sustainable natural resources.
HetCat PD Dr. Reza Fallahpour
Basel · Since 2005
HetCat PD Dr. Reza Fallahpour is a chemical services provider supplying heterocyclic and aromatic intermediates, metal catalysts, ligands and inorganic salts through an extensive product catalog. The company also offers custom synthesis and contract research from mg to kg scale, including process development, scale‑up and logistics support.
HGE-CH GmbH
Brügg Be · Since 2020
HGE-CH GmbH markets Olaris full-spectrum hemp extracts offered as tinctures in MCT carrier oil. The products are presented as cosmetics for skin care, manufactured in Switzerland, and accompanied by external laboratory analysis certificates available per product.
HISTIDE AG
Schindellegi · Since 2014
The core activity of Histide AG is the development and marketing of biotechnological products, in particular so-called Cell Recoding Molecules (CRM), which are intended for the treatment of rare diseases and tissue regeneration. The company focuses on the research and development of non-mutagenic extracellular therapeutic agents and has a strong patent and technology platform.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register